Диссертация (1174225), страница 52
Текст из файла (страница 52)
–P.CD004753.143. Brown J., Farquhar C. Endometriosis: an overview of Cochrane Reviews //Cochrane Database Sys№ Rev. – 2014.144. Brown J., Pan A., Hart R.J. Gonadotrophin-releasing hormone analogues for painassociated with endometriosis. // Cochrane database Sys№ Rev. – 2010. – №12. –P.CD008475.145. Burney R.O., Giudice L.C. Pathogenesis and pathophysiology of endometriosis. //284Fertil.
Steril. – 2012. – Vol. 98, N 3. – P.511-9.146. Burton G.J., Hempstock J., Jauniaux E. Oxygen, early embryonic metabolism andfree radical-mediated embryopathies // Reprod. Biomed. Online. – 2003. – Vol. 6, N 1.– P.84-96.147. Candiani G.B., Danesino V., Gastaldi A. et al. Reproductive and menstrual factorsand risk of peritoneal and ovarian endometriosis. // Fertil. Steril. – 1991. – Vol. 56, N 2.– P.230-4.148. Carneiro M.M., Costa L.M.P., Ávila I.
de. To operate or not to operate on womenwith deep infiltrating endometriosis (DIE) before in vitro fertilization (IVF). // JBRAAssis№ Reprod. – 2017. – Vol. 21, N 2. – P.120-125.149. Caruso S., Cianci S., Vitale S.G. et al. Sexual function and quality of life ofwomen adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg)after abortion for unintended pregnancy.
// Eur. J. Contracep№ Reprod. Health Care. –2018. – Vol. 23, N 1. – P.24-31.150. Casper R.F. Progestin-only pills may be a better first-line treatment forendometriosis than combined estrogen-progestin contraceptive pills // Fertil. Steril. –2017. – Vol. 107, N 3. – P.533-536.151.
Cecchino G.N., García-Velasco J.A. Endometrioma, fertility, and assistedreproductive treatments: connecting the dots. // Curr. Opin. Obste№ Gynecol. – 2018. –Vol. 30, N 4. – P.223-228.152. Celik E., Celik O., Kumbak B. et al. A comparative study on oxidative andantioxidative markers of serum and follicular fluid in GnRH agonist and antagonistcycles // J. Assis№ Reprod. Gene№ – 2012. – Vol. 29, N 11.
– P.1175-1183.153. Chen C., Zhou Y., Hu C. et al. Mitochondria and oxidative stress in ovarianendometriosis. // Free Radic. Biol. Med. – 2019. – Vol. 136. – P.22-34.154. Chen S., Du X., Chen Q., Chen S. Combined Real-Time Three-DimensionalHysterosalpingo-ContrastSonographywithBModeHysterosalpingo-ContrastSonography in the Evaluation of Fallopian Tube Patency in Patients UndergoingInfertility Investigations // Biomed Res. In№ – 2019.
– Vol. 2019. – P.1-7.155. Christiaens F., Janssenswillen C., Verborgh C. et al. Propofol concentrations in285follicular fluid during general anaesthesia for transvaginal oocyte retrieval. // Hum.Reprod. – 1999. – Vol. 14, N 2. – P.345-8.156. Chu J., Harb H.M., Gallos I.D. et al. Salpingostomy in the treatment ofhydrosalpinx: a systematic review and meta-analysis. // Hum. Reprod. – 2015. – Vol.30, N 8.
– P.1882-95.157. Chua S.J., Akande V.A., Mol B.W.J. Surgery for tubal infertility. // Cochranedatabase Sys№ Rev. – 2017. – Vol. 1. – P.CD006415.158. Coccia M.E., Rizzello F., Capezzuoli № et al. Bilateral Endometrioma Excision:Surgery-Related Damage to Ovarian Reserve // Reprod. Sci. – 2019. – Vol. 26, N 4. –P.543-550.159. Cohen J., Mathieu d’Argent E., Selleret L.
et al. Endométriose profonde et fertilité// Presse Med. – 2017. – Vol. 46, N 12. – P.1184-1191.160. Conti N., Cevenini G., Vannuccini S. et al. Women with endometriosis at firstpregnancy have an increased risk of adverse obstetric outcome. // J. Matern. Fetal.Neonatal Med. – 2015.
– Vol. 28, N 15. – P.1795-8.161. Costello M.F., Garad R.M., Hart R. et al. A Review of Second- and Third-lineInfertility Treatments and Supporting Evidence in Women with Polycystic OvarySyndrome // Med. Sci. – 2019. – Vol. 7, N 7. – P.75.162. Cousins F.L., O D.F., Gargett C.E. Endometrial stem/progenitor cells and their rolein the pathogenesis of endometriosis. // Best Prac№ Res. Clin. Obste№ Gynaecol.
–2018. – Vol. 50. – P.27-38.163. Czyzyk A., Podfigurna A., Szeliga A., Meczekalski B. Update on endometriosispathogenesis. // Minerva Ginecol. – 2017. – Vol. 69, N 5. – P.447-461.164. D’Hooghe №M. Clinical relevance of the baboon as a model for the study ofendometriosis. // Fertil. Steril. – 1997. – Vol. 68, N 4. – P.613-25.165. Daniilidis A., Pados G. Comments on the ESHRE recommendations for thetreatment of minimal endometriosis in infertile women // Reprod. Biomed. Online.
–2018. – Vol. 36, N 1. – P.84-87.166. Daraï E., Cohen J., Ballester M. Colorectal endometriosis and fertility. // Eur. J.Obste№ Gynecol. Reprod. Biol. – 2017. – Vol. 209. – P.86-94.286167. Dawood A.S., Elgergawy A.E. Incidence and sites of pelvic adhesions in womenwith post-caesarean infertility. // J. Obste№ Gynaecol.
– 2018. – Vol. 38, N 8. – P.11581163.168. Depmann M., Broer S.L., Eijkemans M.J.C. et al. Anti-Müllerian hormone doesnot predict time to pregnancy: results of a prospective cohort study // Gynecol.Endocrinol. – 2017. – Vol. 33, N 8. – P.644-648.169.
Ding G.-L., Chen X.-J., Luo Q. et al. Attenuated oocyte fertilization and embryodevelopment associated with altered growth factor/signal transduction induced byendometriotic peritoneal fluid. // Fertil. Steril. – 2010. – Vol. 93, N 8. – P.2538-44.170. Dogan E., Okyay E., Saatli B.
et al. Tuba ovarian abscesses formation fromdecidualized ovarian endometrioma after appendiceal endometriosis presenting as acuteappendicitis in pregnancy. // Iran. J. Reprod. Med. – 2012. – Vol. 10, N 3. – P.275-8.171. Donnez J., Nisolle M., Gillet N. et al. Large ovarian endometriomas // Hum.Reprod. – 1996.
– Vol. 11, N 3. – P.641-645.172. Dorien O., Flores I., Waelkens E., D’Hooghe № Noninvasive diagnosis ofendometriosis: Review of current peripheral blood and endometrial biomarkers. // BestPrac№ Res. Clin. Obste№ Gynaecol. – 2018. – Vol. 50. – P.72-83.173. Dunselman G.A.J., Vermeulen N., Becker C.
et al. ESHRE guideline: managementof women with endometriosis // Hum. Reprod. – 2014. – Vol. 29, N 3. – P.400-412.174. Ekarattanawong S., Tanprasertkul C., Somprasit C. et al. Possibility of usingsuperoxide dismutase and glutathione peroxidase as endometriosis biomarkers // In№ J.Womens. Health. – 2017. – Vol. Volume 9. – P.711-716.175. Elahian F., Sepehrizadeh Z., Moghimi B., Mirzaei S.A. Human cytochrome b5reductase: structure, function, and potential applications.
// Cri№ Rev. Biotechnol. –2014. – Vol. 34, N 2. – P.134-43.176. Emidio G. Di, D’Alfonso A., Leocata P. et al. Increased levels of oxidative andcarbonyl stress markers in normal ovarian cortex surrounding endometriotic cysts //Gynecol. Endocrinol. – 2014. – Vol. 30, N 11.
– P.808-812.177. Ersahin A.A., Arpaci H., Ersahin S.S. et al. AFC vs. AMH: prediction of ovarianresponse in women with endometrioma undergoing controlled ovarian stimulation. //287Eur. Rev. Med. Pharmacol. Sci. – 2017. – Vol. 21, N 10. – P.2499-2503.178.
Exacoustos C., Lauriola I., Lazzeri L. et al. Complications during pregnancy anddelivery in women with untreated rectovaginal deep infiltrating endometriosis. // Fertil.Steril. – 2016. – Vol. 106, N 5. – P.1129-1135.e1.179. Fanchin R. Serum anti-Mullerian hormone is more strongly related to ovarianfollicular status than serum inhibin B, estradiol, FSH and LH on day 3 // Hum. Reprod.– 2003.
– Vol. 18, N 2. – P.323-327.180. Fauser B.C.J.M., Heusden A.M. van. Manipulation of Human Ovarian Function:Physiological Concepts and Clinical Consequences* // Endocr. Rev. – 1997. – Vol. 18,N 1. – P.71-106.181.Fernando S.,Breheny S.,Jaques A.M.etal.Pretermbirth,ovarianendometriomata, and assisted reproduction technologies. // Fertil. Steril. – 2009. – Vol.91, N 2. – P.325-30.182. Flyckt R., Kim S., Falcone № Surgical Management of Endometriosis in Patientswith Chronic Pelvic Pain. // Semin. Reprod.
Med. – 2017. – Vol. 35, N 1. – P.54-64.183. Foda A.A., Aal I.A.A. Role of some biomarkers in chronic pelvic pain for earlydetection of endometriosis in infertile women // Middle East Fertil. Soc. J. – 2012. –Vol. 17, N 3. – P.187-194.184. Frank P., McNamee R., Hannaford P.C. et al. The effect of induced abortion onsubsequent fertility. // Br. J. Obste№ Gynaecol. – 1993. – Vol. 100, N 6. – P.575-80.185. Freitas C., Neto A.C., Matos L.